Personalization of Pharmacological Treatments for ADHD: Why it is Advisable and Possible Options to Achieve it
- Wendy Verónica Herrera-Morales,
- Leticia Ramírez-Lugo,
- Roger Cauich-Kumul,
- ,
- Luis Núñez-Jaramillo
- Universidad de Quintana Roo,
- Universidad Nacional Autónoma de México,
- ,
- Intercontinental Neuroscience Research Group
Publication Information
Tipo de resultado
Idioma original
InglésPáginas desde-hasta (Número de páginas)
Páginas 1236-1249 (14 páginas)Revista (Volumen, Número de Edición)
Current Topics in Medicinal Chemistry (Volumen 22, Número 15)Hitos de publicación
- Publicada - 01/06/2022
Estado de publicación
ISSN
1568-0266Publication IDs
- Scopus: 85135165527
- PubMed: 35579123
Abstract
Attention-deficit hyperactivity disorder is a neurodevelopmental disorder diagnosed pri-marily in children, although it is also present in adults. Patients present inattention, impulsivity, and hyperactivity symptoms that create difficulties in their daily lives. Pharmacological treatment with stimulants or non-stimulants is used most commonly to reduce ADHD symptoms. Although gener-ally effective and safe, pharmacological treatments have different effects among patients, including lack of response and adverse reactions. The reasons for these differences are not fully understood, but they may derive from the highly diverse etiology of ADHD. Strategies to guide optimal pharmacological treatment selection based on individual patients’ physiological markers are being de-veloped. In this review, we describe the main pharmacological ADHD treatments used and their main drawbacks. We present alternatives under study that would allow the customization of pharmacological treatments to overcome these drawbacks and achieve more reliable improvement of ADHD symptoms.
